Allogeneic NK cell infusion

allogeneic natural killer cells · Coeptis Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic NK cell infusion, covering 2024-07-19 to 2024-07-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Allogeneic NK Cell Infusions in Patients With Relapsed/Refractory AML and High Risk MDS [Phase 1]

See pricing